Monday 9 November 2026 Export IMRX’s income statement to Excel — free account

Immuneering Corporation

IMRX

Healthcare Biotechnology

Immuneering Corporation’s revenue for fiscal 2022 (year ended December 2022) was $317,000.00.

EPS: +1.61%
Free cash flow: −40.2%

Quarter to September 2026, against a year earlier

Insider buying

3.68 0.31 +9.20%

Follow IMRX

Alert me

Market cap: $238.3M
P/E: n/m
Fwd P/E: n/m
Dividend yield: —
F-score: 3/9
ROIC: −198.4%
Net debt / EBITDA: 2.9×
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	—	—	—	—	+8 more quarters Free account
EV/Sales Full definition →	—	—	—	—
EV/FCF Full definition →	—	—	—	—
Quick Ratio Full definition →	13.47	18.47	31.50	17.16
Current Ratio Full definition →	13.97	19.47	32.45	17.50
Net Debt/EBITDA Full definition →	5.60	7.73	10.07	12.58
Debt/Assets Full definition →	0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.69	0.96	1.37	0.85
Capex/Depreciation Full definition →	0.09	0.07	0.36	(7.33)
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Intangible Assets out of Total Assets Full definition →	0.04	0.03	0.03	0.03
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Yield Full definition →	—	—	—	—
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.26)	(0.26)	(0.29)	(0.22)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.26)	(0.26)	(0.29)	(0.23)
Cash per Share Full definition →	2.25	2.32	2.42	3.93
Shareholders Equity per Share Full definition →	2.61	2.95	3.19	4.96
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	2.61	2.95	3.19	4.96
Free Cash Flow Full definition →	(16.80)	(16.53)	(18.51)	(9.96)
Working Capital Full definition →	139.92	149.87	156.43	166.17
Capital Expenditures Full definition →	(0.02)	(0.03)	(0.08)	(0.12)
Net Current Asset Value Full definition →	136.83	146.67	153.12	162.75
EV/EBIT Full definition →	—	—	—	—
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →	2.18	2.89	1.38	1.75
Average Assets Full definition →	211.81	121.06	132.75	142.35
Average Common Equity Full definition →	198.33	109.84	124.18	129.94

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly